Buyouts
Blue Ocean Capital exits China Cord Blood
China-focused PE firm Blue Ocean Capital has exited US-listed China Cord Blood Corporation (CCBC), by selling its beneficial interest in the blood bank operator to a fund sponsored by Chinese conglomerate Sanpower Group.
Tech M&A: Tactical forays
A new generation of Chinese technology companies – conscious of the need to stay competitive – are becoming more active M&A players as they choose to buy rather than build their way into multiple verticals
China-Australia: Communication breakdown
A couple of high-profile rejections of Chinese deals overshadow the fact that most foreign investments in the country receive approval. Prospective buyers are advised to engage with interested parties from the outset
KKR sweetens tender offer for Japan's Hitachi Kokusai
KKR has improved its tender offer for Japanese high-tech manufacturer Hitachi Kokusai Electric after the process, which was announced in April, stalled due to share price volatility.
China M&A: Exit options
The growth in outbound M&A among Chinese investors has created significant exit opportunities for PE investors
Regulation: Dialogue in the dark
The Committee on Foreign Investment in the US has a huge a backlog of applications to process and a staffing shortage. Potential buyers have little choice but to be patient
Q&A: Zhong Lun's Yun Zhou
Yun Zhou, a partner with Chinese law firm Zhong Lun, discusses the effects of Chinese government guidelines on outbound investment in terms of who will be doing these deals, and how
One Belt One Road: Probationary bonanza
China’s One Belt One Road agenda is set to be a driving force in M&A activity that reshapes economies across Eurasia for decades to come. Early movers are consequently negotiating a new world of variables
China M&A: Outbound 2.0
Following the issuance of regulatory guidance, the aggression and opportunism that once characterized corporate China’s approach to overseas M&A will be replaced by moderation and consideration
India’s Samara acquires drug portfolio from Novartis
Samara Capital Partners has acquired the Indian rights to a portfolio of drug brands from Swiss pharmaceutical company Novartis.
Provident joins $138m bid for Indonesian mining project
Provident Capital has joined a consortium of investors in a bid to acquire Finders Resources that values the Indonesian mining project developer at about A$177.7 million ($138 million).
Bain launches $1.3b tender offer for Japanese ad agency
Bain Capital Private Equity has launched a tender offer for Japan-based advertising agency Asatsu-DK (ADK) that values the company at JPY151 billion ($1.3 billion).
Japan carve-outs: Slow burn story
Toshiba Memory Corporation is set to become Asia'a largest-ever PE buyout, if the deal goes through in its current form. But this doesn't necessarily mean the path to corporate divestments in Japan will become smoother
MBK to buy stake in Korean golf course business
MBK Partners, which completed its acquisition of Japanese golf course operator Accordia Golf earlier this year, has agreed to take a stake in the golf course management business of Korea-listed Golfzon.
PE investors abandon Australia childcare merger
Outside school care providers Camp Australia and Junior Adventures Group (JAG), which are owned by Bain Capital Private Equity and Advent Partners, respectively, have abandoned plans to merge.
China’s 51Job acquires majority stake in VC-backed Lagou
US-listed Chinese recruitment site 51Job has agreed to acquire a 60% stake in industry peer Beijing Lagou Network Technology, which is backed by Qiming Venture Partners and other VC investors, for $119 million.
Tower Capital backs $204m Singapore logistics take-private
Tower Capital Asia is supporting a take-private bid for Poh Tiong Choon Logistics that values the Singapore-listed company at approximately S$275 million ($204 million).
Toshiba agrees $18b sale of chip unit to Bain consortium
Japanese conglomerate Toshiba Corporation has reached a final agreement to sell its Nand flash memory unit to a consortium led by Bain Capital for JPY2 trillion ($17.8 billion).
Trump blocks sale of Lattice Semiconductor to Chinese GP
US President Donald Trump has vetoed the sale of US-based chip maker Lattice Semiconductor to Canyon Bridge Capital Partners, a private equity firm backed by Chinese LPs, citing national security concerns.
Toshiba, Bain sign MOU for chip unit - update
Japanese conglomerate Toshiba has signed a memorandum of understanding (MOU) with Bain Capital regarding the sale of its Nand flash memory unit to a consortium led by the PE firm.
Japan's J-Star exits pet services business
J-Star has made a full exit from Japanese pet services business Three Arrows to domestic GP Création Capital, its co-investor on the original deal.
FountainVest to buy German turbocharger business
China’s FountainVest Partners has agreed to acquire 100% of Bosch Mahle Turbo Systems (BMTS), a German automotive industry supplier with an existing production and sales presence in Shanghai.
GPs must be selective in targeting Korea divestments – AVCJ Forum
Korea's push for chaebol reform is expected to create more PE investment opportunities as conglomerates are pressured to divest assets, but GPs told the AVCJ Korea Forum that they have to be careful in picking the right deals because asset quality varies.
Deal focus: Lock & Lock primed for regional expansion
Affinity Equity Partners is betting on Asian appetites for high-quality food containers in its acquisition of South Korea's Lock & Lock